(CLA-B) Cloetta (publ) - Ratings and Ratios
Exchange: ST • Country: Sweden • Currency: SEK • Type: Common Stock • ISIN: SE0002626861
CLA-B: Chocolate, Pralines, Dragees, Liquorice, Toffees, Candy, Nuts
Cloetta AB (publ) is a seasoned player in the confectionery industry, operating through two distinct segments: Branded Packaged Products and Pick & Mix. The company has a rich history dating back to 1862, giving it a deep understanding of consumer preferences and market dynamics.
Under its Branded Packaged Products segment, Cloetta offers a diverse portfolio of chocolate confectionery products, including pralines, wafers, and countlines under notable brands like Kexchoklad, Polly, and Plopp. These brands have established a strong market presence, leveraging traditional recipes and innovative packaging to maintain customer loyalty.
The company also excels in non-chocolate confectionery, offering a variety of products such as foams, wine gums, and liquorice under brands like Malaco, Red Band, and Ahlgrens bilar. This diversification allows Cloetta to cater to a broad spectrum of consumer tastes, enhancing its market reach and resilience.
Cloettas product range extends to pastilles and chewing gums, with brands like Läkerol and Jenkki, known for their quality and enduring appeal. Additionally, the company markets dry roasted nuts under the Nutisal brand, further diversifying its offerings in the snack segment.
From a financial standpoint, Cloetta boasts a market capitalization of 8,015.56M SEK, with a P/E ratio of 16.63, indicating a valuation that reflects its stable earnings and growth prospects. The price-to-sales ratio of 0.93 suggests an attractive valuation relative to its revenue, making it a noteworthy consideration for investors seeking exposure to the consumer goods sector.
Operationally, Cloetta maintains a strong distribution network across multiple regions, including Scandinavia, the Netherlands, Germany, and the UK. This extensive reach, combined with strategic e-commerce initiatives, positions the company to capitalize on evolving consumer purchasing behaviors and market trends.
Headquartered in Sundbyberg, Sweden, Cloettas strategic approach to brand management and product innovation underscores its commitment to sustainable growth and profitability, aligning with the interests of both investors and fund managers seeking stable returns in the consumer staples arena.
Additional Sources for CLA-B Stock
CLA-B Stock Overview
Market Cap in USD | 766m |
Sector | Consumer Defensive |
Industry | Confectioners |
GiC Sub-Industry | Packaged Foods & Meats |
IPO / Inception |
CLA-B Stock Ratings
Growth 5y | 34.1% |
Fundamental | 58.7% |
Dividend | 53.3% |
Rel. Strength Industry | 48.8 |
Analysts | - |
Fair Price Momentum | 29.71 SEK |
Fair Price DCF | 49.62 SEK |
CLA-B Dividends
Dividend Yield 12m | 8.21% |
Yield on Cost 5y | 11.15% |
Annual Growth 5y | -7.79% |
Payout Consistency | 62.4% |
CLA-B Growth Ratios
Growth Correlation 3m | 57.5% |
Growth Correlation 12m | 94.4% |
Growth Correlation 5y | -1.6% |
CAGR 5y | 8.04% |
CAGR/Max DD 5y | 0.20 |
Sharpe Ratio 12m | 1.48 |
Alpha | 55.99 |
Beta | 0.16 |
Volatility | 19.55% |
Current Volume | 231.4k |
Average Volume 20d | 242.2k |
As of March 15, 2025, the stock is trading at SEK 27.76 with a total of 231,362 shares traded.
Over the past week, the price has changed by +2.74%, over one month by -2.39%, over three months by +7.85% and over the past year by +61.03%.
Partly, yes. Based on ValueRay Fundamental Analyses, Cloetta (publ) (ST:CLA-B) is currently (March 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 58.71 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of CLA-B as of March 2025 is 29.71. This means that CLA-B is currently overvalued and has a potential downside of 7.02%.
Cloetta (publ) has no consensus analysts rating.
According to ValueRays Forecast Model, CLA-B Cloetta (publ) will be worth about 32.1 in March 2026. The stock is currently trading at 27.76. This means that the stock has a potential upside of +15.6%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 23 | -17.1% |
Analysts Target Price | - | - |
ValueRay Target Price | 32.1 | 15.6% |